FORM F-X
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-X
APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING
A.   Name of issuer or person filing (“Filer”): Mindray Medical International Limited
 
B.   This is [check one]:
 
    þ An original filing for the Filer
 
    o An amended filing for the Filer
 
C.   Identify the filing in conjunction with which this Form is being filed: Form CB
 
    Name of registrant: Mindray Medical International Limited
 
    Form type: Form CB
 
    File Number (if known): 333-140341
 
    Filed by: Mindray Medical International Limited
 
    Date Filed (if filed concurrently, so indicate): March 11, 2009 (concurrently with Form CB)
 
D.   The Filer is incorporated or organized under the laws of the Cayman Islands and has its principal place of business at:
Mindray Building
Keji 12th Road South
Hi-tech Industrial Park, Nanshan
Shenzhen 518057
People’s Republic of China
(86-755) 2658-2888
E.   The Filer designates and appoints CT Corporation System (“Agent”) located at:
CT Corporation System
111 Eighth Avenue, 13th Floor
New York, New York 10011
(212) 894-8940
as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:
  (a)   any investigation or administrative proceeding conducted by the Commission; and
 
  (b)   any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns (i) any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form CB on March [9], 2009 or any purchases or sales of any security in connection therewith; (ii) the securities in relation to which the

 


 

      obligation to file an annual report on Form 40-F arises, or any purchases or sales of such securities; (iii) any tender offer for the securities of a Canadian issuer with respect to which filings are made by the Filer with the Commission on Schedule 13E-4F, 14D-1F or 14D-9F; or (iv) the securities in relation to which the Filer acts as trustee pursuant to an exemption under Rule 10a-5 under the Trust Indenture Act of 1939. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that service of an administrative subpoena shall be effected by service upon such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.
F.   The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed following the effective date of the latest amendment to such Form CB.
 
    The Filer further undertakes to advise the Commission promptly of any change to the Agent’s name or address during the applicable period by amendment of this Form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.
 
G.   The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the Forms, Schedules and offering statements described in General Instructions I.(a), I.(b), I.(c), I.(d) and I.(f) of this Form, as applicable; the securities to which such Forms, Schedules and offering statements relate; and the transactions in such securities.
The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereto duly authorized, in Shenzhen, China, this 11th day of March, 2009.
         
Filer:  MINDRAY MEDICAL INTERNATIONAL LIMITED
 
 
  By:   /s/ Joyce I-Yin Hsu    
    Name:   Joyce I-Yin Hsu   
    Title:   Chief Financial Officer   
 

 


 

This statement has been signed by the following person in the capacity and on the date indicated.
         
  CT CORPORATION SYSTEM
As Agent for Service of Process for
Mindray Medical International Limited
 
 
  By:   /s/ Donald J. Puglisi    
    Name:   Donald J. Puglisi   
    Title:   Managing Director  
 
    Date:   March 11, 2009